Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer

BACKGROUND: Given the greatly elevated risks of contralateral breast cancer (CBC) observed in breast cancer patients who carry mutations in BRCA1 and BRCA2, it is critical to determine the effectiveness of standard adjuvant therapies in preventing CBC in mutation carriers. METHODS: The WECARE study...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Reding, Kerryn W., Bernstein, Jonine L., Langholz, Bryan M., Bernstein, Leslie, Haile, Robert W., Begg, Colin B., Lynch, Charles F., Concannon, Patrick, Borg, Ake, Teraoka, Sharon N., Törngren, Therese, Diep, Anh, Xue, Shanyan, Bertelsen, Lisbeth, Liang, Xiaolin, Reiner, Anne S., Capanu, Marinela, Malone, Kathleen E.
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2903659/
https://ncbi.nlm.nih.gov/pubmed/20135344
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-010-0769-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados